AMLODIPINE AND OLMESARTAN MEDOXOMIL
Generic: AMLODIPINE AND OLMESARTAN MEDOXOMIL
AMLODIPINE AND OLMESARTAN MEDOXOMIL is FDA application ANDA209042, sponsored by ALKEM LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from
Failed Dissolution Specifications: low dissolution results
cGMP deviations
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
CGMP Deviations: Intermittent exposure to temperature excursion during storage.